Qube Research & Technologies (QRT)
TBIO

Qube Research & Technologies (QRT)’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-23
Closed -$84 – 4321
2024
Q2 		$84 Buy
23
+1
+5% +$5 ﹤0.01% 3447
2024
Q1 		$178 Buy
+22
New +$165 ﹤0.01% 4146
2023
Q4 		– Sell
-361
Closed -$4.01K – 4257
2023
Q3 		$6.76K Buy
+361
New +$8.79K ﹤0.01% 3394
2022
Q4 		– Sell
-989
Closed -$30K – 3105
2022
Q3 		$30K Buy
989
+111
+13% +$3.91K ﹤0.01% 2237
2022
Q2 		$28K Buy
+878
New +$60.6K ﹤0.01% 2219
2021
Q3 		– Sell
-852
Closed -$337K – 2898
2021
Q2 		$337K Buy
+852
New +$301K ﹤0.01% 1511

Other funds holding TBIO

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TBIO Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2024, closing a stake of 23 shares — an estimated $84 sold.

Qube Research & Technologies (QRT) first reported a position in TBIO in Q2 2021 and held it in 6 quarters. The position peaked at $337K in Q2 2021. 1 fund tracked by Wall St. Rank holds TBIO as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 23 Telesis Bio, Inc. Common Stock shares in Q3 2024, an estimated $84.
  • Qube Research & Technologies (QRT) first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Telesis Bio, Inc. Common Stock position peaked at $337K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.